FDA Clarifies Stance on Clinical Trial Reimbursements

The FDA updated its guidance to institutional review boards and clinical investigators, detailing its views on reimbursements for lodging and travel for clinical trial participants.
Source: International Pharmaceutical Regulatory Monitor